“Just So Grateful.” Artemis II Crew & Eli Lilly’s New GLP-1 Pill 4/30/26
Home from space, the crew of the Artemis II stops by the Squawk set. Commander Reid Wiseman, Pilot Victor Glover, and Mission Specialists Christina Koch and Jeremy Hansen discuss their brave journey around the moon, the newest frontiers, the emotional and physical toll of takeoff and reentry, and handling snafus–like smoke alarms and toilet troubles–while in space. Eli Lilly CEO David Ricks discusses the drugmaker’s big financial quarter in an exclusive interview. He shares the first prescription numbers of Lilly’s newest GLP-1 pill, Foundayo, as well as how it differs from Zepbound and Novo Nordisk’s Wegovy. Plus, Anthropic is in talks to raise funds at a $900B valuation, the Saudi Public Investment Fund will stop funding the LIV Golf League, and Jerome Powell will remain on the Fed’s Board of Governors after his time as Chairman ends. Steve Liesman - 3:17 Angelica Peebles & David Ricks - 17:12 Artemis II Crew - 32:06 In this episode: Artemis Crew, @NASAArtemis Steve Liesman, @steveliesman Angelica Peebles, @angelicapeebles Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Cameron Costa, @CameronCostaNY
You May Also Like

SECRETOS DE UN EMPRENDEDOR
Streamla

Marketplace
Marketplace

Marketplace All-in-One
Marketplace

Stock Movers
iHeartPodcasts

Bloomberg Talks
Bloomberg

The Personal Wealth Coach
Jacob A. McClure, CIMA®, of The Personal Wealth Coach, an Independent Fiduciary Investment Advisory Firm | Fee-Only

How to Trade Stocks and Options Podcast with OVTLYR Live
Christopher M. Uhl, CMA

Mission Matters Business Podcast with Adam Torres
Adam Torres

Mining Stock Daily
Trevor Hall

Fitness Business University Podcast
Vince Gabriele
Community discussion